BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32911327)

  • 1. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
    Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
    Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
    Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
    Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
    Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
    Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
    Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
    Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
    Guyon A; Rousseau J; Lamothe G; Tremblay JP
    PLoS One; 2020; 15(12):e0237122. PubMed ID: 33370284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
    Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
    Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
    Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
    Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
    Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease.
    Bamne MN; Demirci FY; Berman S; Snitz BE; Rosenthal SL; Wang X; Lopez OL; Kamboh MI
    Neurobiol Aging; 2014 Jul; 35(7):1779.e15-6. PubMed ID: 24529499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
    Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
    Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
    Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
    Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
    Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
    Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
    Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases.
    Ting SK; Chong MS; Kandiah N; Hameed S; Tan L; Au WL; Prakash KM; Pavanni R; Lee TS; Foo JN; Bei JX; Yu XQ; Liu JJ; Zhao Y; Lee WL; Tan EK
    Neurobiol Aging; 2013 Oct; 34(10):2441.e7-8. PubMed ID: 23652020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
    Wang LS; Naj AC; Graham RR; Crane PK; Kunkle BW; Cruchaga C; Murcia JD; Cannon-Albright L; Baldwin CT; Zetterberg H; Blennow K; Kukull WA; Faber KM; Schupf N; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Rogaeva E; ; Lin CF; Dombroski BA; Cantwell LB; Partch A; Valladares O; Hakonarson H; St George-Hyslop P; Green RC; Goate AM; Foroud TM; Carney RM; Larson EB; Behrens TW; Kauwe JS; Haines JL; Farrer LA; Pericak-Vance MA; Mayeux R; Schellenberg GD; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barmada M; Barnes LL; Beach TG; Becker JT; Beecham GW; Beekly D; Bennett DA; Bigio EH; Bird TD; Blacker D; Boeve BF; Bowen JD; Boxer A; Burke JR; Buxbaum JD; Cairns NJ; Cao C; Carlson CS; Carroll SL; Chui HC; Clark DG; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Demirci FY; Dick M; Dickson DW; Duara R; Ertekin-Taner N; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Graff-Radford NR; Growdon JH; Hamilton RL; Hamilton-Nelson KL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jarvik GP; Jicha GA; Jin LW; Jun G; Jun G; Kamboh MI; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lopez OL; Lunetta KL; Lyketsos CG; Mack WJ; Marson DC; Martin ER; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam WM; Miller BL; Miller CA; Miller JW; Montine TJ; Morris JC; Murrell JR; Olichney JM; Parisi JE; Perry W; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reiman EM; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Saykin AJ; Schneider JA; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Tsuang DW; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
    JAMA Neurol; 2015 Feb; 72(2):209-16. PubMed ID: 25531812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population.
    Kero M; Paetau A; Polvikoski T; Tanskanen M; Sulkava R; Jansson L; Myllykangas L; Tienari PJ
    Neurobiol Aging; 2013 May; 34(5):1518.e1-3. PubMed ID: 23102935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.